MDxHealth (MDXH) Other financing activities (2021 - 2026)

MDxHealth has disclosed Other financing activities across 5 years of filings, most recently posting -$2.4 million for Q1 2026.

• Other financing activities for Q1 2026 came in at -$2.4 million, down 25.06% year-over-year; the trailing twelve-month figure through Mar 2026 was -$16.1 million (down 167.01% YoY), and the FY2025 annual result was -$9.7 million, down 45.18% from the prior year.
• Other financing activities came in at -$2.4 million for Q1 2026 at MDxHealth, up from -$7.2 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of -$240000.0 in Q1 2022 to a low of -$7.2 million in Q3 2025.
• The 4-year median for Other financing activities is -$2.0 million (2024), against an average of -$2.6 million.
• Across the five-year window, Other financing activities sank 256.79% in 2025 and decreased 25.06% in 2026, its largest moves.
• MDxHealth's Other financing activities stood at -$271000.0 in 2022, then plunged by 565.31% to -$1.8 million in 2024, then tumbled by 297.95% to -$7.2 million in 2025, then jumped by 65.85% to -$2.4 million in 2026.
• The last three Other financing activities figures came in at -$2.4 million (Q1 2026), -$7.2 million (Q3 2025), and -$4.6 million (Q2 2025), per Business Quant data.